elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37067591-126EB053-BF00-4BD8-B03F-9C7DE52BA50D
Q37067591-126EB053-BF00-4BD8-B03F-9C7DE52BA50D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37067591-126EB053-BF00-4BD8-B03F-9C7DE52BA50D
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.
P2093
Q37067591-126EB053-BF00-4BD8-B03F-9C7DE52BA50D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37067591-126EB053-BF00-4BD8-B03F-9C7DE52BA50D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9591924946d37eeb08e0f9ae237e7d46700b08af
P1545
3
http://www.w3.org/2001/XMLSchema#string
P2093
D Ganea-Motan
http://www.w3.org/2001/XMLSchema#string